Symposium:
132. Pediatric Transplant ID
Friday, October 4, 2013: 2:00 PM-3:30 PM
Room: The Moscone Center: 130-131 (Hall E)

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • discuss the respiratory viral infections and invasive fungal infections and their timing after transplantation affecting pediatric transplant patients
  • describe the mechanism and timing of reactivation of the herpes viruses and their infectious syndromes in pediatric transplant patients
  • review the available treatment options for the various infections

Target Audience: pharmacists, microbiologists, members-in-training, lab personnel, infectious diseases physicians, infectious diseases pediatricians, infection preventionists, hospital epidemiologists, health care workers, fellows, epidemiologists, clinicians, academicians

Tracks: Pediatric ID

Moderators:  Janet A. Englund, MD, FIDSA, Seattle Children's Hospital and Tina Tan, MD, FIDSA, Northwestern University Feinberg School of Medicine

Presentations:

2:00 PM
Respiratory Viruses in Transplant Patients
Janet A. Englund, MD, FIDSA

CME Credits: Maximum of 1.5 hours of AMA PRA Category 1 CreditTM

ACPE Credits: ACPE 1.5 knowledge-based contact hours (0.15 CEU) of pharmacy CE

ACPE Number: 0221-9999-13-088-L01-P

Disclosures:

J. A. Englund, PIDS: Board Member, None
Chimerix: Investigator, Research support
Gilead: Investigator, Research support
Novartis: Investigator, Research support
GlaxoSmithKline: Consultant, Consulting fee

T. Tan, None

J. A. Englund, PIDS: Board Member, None
Chimerix: Investigator, Research support
Gilead: Investigator, Research support
Novartis: Investigator, Research support
GlaxoSmithKline: Consultant, Consulting fee

L. Danziger-Isakov, None

C. Blyth, Pfizer Global: Grant Investigator, Research grant
Gilead Science: Grant Investigator, Research grant
Merck Sharp & Dohme: Grant Investigator, Grant recipient

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 2nd with the exception of research findings presented at the IDWeek press conferences.